WHO ICTRP trial

To investigate if administration of methylprednisone before surgery could…

ISRCTN16524336 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN16524336
Public title To investigate if administration of methylprednisone before surgery could decrease the incidence of urosepsis postoperative in patients with high risks undergoing percutaneous nephrolithotomy
Scientific title The effectiveness of methylprednisone to pevent urosepsis after percutaneous nephrolithotomy in patients with high risk
Primary sponsor Changhai Hospital of Shanghai
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries China
Conditions Urosepsis after percutaneous nephrolithotomy Infections and Infestations Urosepsis
Interventions Current interventions as of 24/09/2018: After induction of general anesthesia, participants are allocated to one of two groups using stratified block randomization, with the stratified factor being gender. In group M, the participants are…
Registration date May 21, 2018
Target size 100
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations